{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:23:39Z","timestamp":1752549819949,"version":"3.41.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jiac.2025.102737","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T14:56:48Z","timestamp":1748098608000},"page":"102737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality"],"prefix":"10.1016","volume":"31","author":[{"given":"Yuko","family":"Danzuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6627-0340","authenticated-orcid":false,"given":"Keiji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-9036","authenticated-orcid":false,"given":"Shinya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Etoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-7659","authenticated-orcid":false,"given":"Sho","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-5130","authenticated-orcid":false,"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102737_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31617","article-title":"SARS-CoV-2 infection, hospitalization, and mortality in adults with and without cancer","volume":"6","author":"Hosseini-Moghaddam","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2025.102737_bib2","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1002\/ajh.26626","article-title":"Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report","volume":"97","author":"Blennow","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2025.102737_bib3","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102737_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102631","article-title":"Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients","volume":"31","author":"Kamegai","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102737_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148635","article-title":"SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes","volume":"131","author":"Li","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jiac.2025.102737_bib6","doi-asserted-by":"crossref","first-page":"e2995","DOI":"10.1093\/cid\/ciaa1285","article-title":"Severe acute respiratory syndrome coronavirus 2 RNA in serum as predictor of severe outcome in coronavirus disease 2019: a retrospective cohort study","volume":"73","author":"Hagman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/cid\/ciab394","article-title":"SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19","volume":"74","author":"Ram-Mohan","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib8","doi-asserted-by":"crossref","first-page":"ofac463","DOI":"10.1093\/ofid\/ofac463","article-title":"Correlation of SARS-CoV-2 nasopharyngeal Ct values with viremia and mortality in adults hospitalized with COVID-19","volume":"9","author":"Hagman","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23923-1","article-title":"Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients","volume":"12","author":"Rovito","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2025.102737_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/infdis\/jiac157","article-title":"Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19","volume":"226","author":"Jacobs","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281052","article-title":"SARS-CoV-2 viremia and COVID-19 mortality: a prospective observational study","volume":"18","author":"Giacomelli","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2025.102737_bib12","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMc2100362","article-title":"V-2 variants \u2013 clinical, public health, and vaccine implications","volume":"384","author":"Abdool Karim","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102737_bib13","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1038\/s41467-024-47941-x","article-title":"Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19","volume":"15","author":"Igari","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2025.102737_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2025.102737_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.86","article-title":"Prolonged lymphocytopenia after Bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma","volume":"5","author":"Saito","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jiac.2025.102737_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2016.152272","article-title":"Safety and efficacy of obinutuzumab with CHOP or Bendamustine in previously untreated follicular lymphoma","volume":"102","author":"Grigg","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jiac.2025.102737_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41408-022-00684-8","article-title":"Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review","volume":"12","author":"Piechotta","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jiac.2025.102737_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ccell.2021.09.001","article-title":"Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jiac.2025.102737_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 variants in patients with immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102737_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113077","article-title":"SARS-CoV-2 variants with NSP12 P323L\/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jiac.2025.102737_bib21","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.5808\/GI.2020.18.4.e44","article-title":"Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19","volume":"18","author":"Biswas","year":"2020","journal-title":"Genomics Inform"},{"key":"10.1016\/j.jiac.2025.102737_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91662-w","article-title":"Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant","volume":"11","author":"Ilmj\u00e4rv","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2025.102737_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13059-023-02881-5","article-title":"The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection","volume":"24","author":"Goldswain","year":"2023","journal-title":"Genome Biol"},{"key":"10.1016\/j.jiac.2025.102737_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00222-22","article-title":"Remdesivir and GS-441524 retain rativiral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants","volume":"66","author":"Pitts","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102737_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jiac.2025.102737_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac050","article-title":"Recurrent SARS-CoV-2 mutations in immunodeficient patients","volume":"8","author":"Wilkinson","year":"2022","journal-title":"Virus Evol"},{"key":"10.1016\/j.jiac.2025.102737_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102737_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"Edalatifard","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2025.102737_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12879-021-06045-3","article-title":"Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial","volume":"21","author":"Ranjbar","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-020-04078-1","article-title":"High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study","volume":"40","author":"Monreal","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13054-023-04337-5","article-title":"Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: nationwide clinical cohort study","volume":"27","author":"Moromizato","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2025.102737_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/cid\/ciad085","article-title":"Successful combination treatment for persistent severe acute respiratory syndrome coronavirus 2 infection","volume":"76","author":"Blennow","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102737_bib35","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/jac\/dkad295","article-title":"Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19","volume":"78","author":"Hagman","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T07:03:44Z","timestamp":1749711824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1341321X25001345"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102737","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102737"}}